Aquestive Therapeutics rises after $85 million stock sale

Aquestive Therapeutics

14/08/2025 19:19

** Drugmaker Aquestive Therapeutics' AQST.O shares rise 5.4% to $4.23

** AQST announces pricing of $85 million stock offering

** Co sold ~21.3 million shares at $4 apiece, just 0.2% discount to stock's last close

** Proceeds will be used to advance the launch and commercialization of epinephrine sublingual film for the treatment of severe, life-threatening allergic reactions and other purposes

** Offering led by RTW Investments and included participation from Samsara BioCapital, EcoR1 Capital, Perceptive Advisors, Sio Capital Management, ADAR1 Capital Management and Nantahala Capital

** Leerink Partners, Cantor, and Oppenheimer were joint bookrunning managers for the offering

** All nine brokerages covering the stock rate "buy" or higher; median PT $8 - data compiled by LSEG

** As of last close, AQST stock up 12.6% YTD

(Reporting by Arasu Kannagi Basil in Bengaluru)

((ArasuKannagi.Basil@thomsonreuters.com))